| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.084 | 0.04 |